C07D 209/92
Naphthostyrils
C07D209/92 (Naphthostyrils) appears on 36 US grants and 24 published applications in this corpus.
Search patents in C07D- Granted patents
- 36
- Published applications
- 24
- Assignees
- 29
- Inventors
- 121
- Latest grant
- 29 Aug 2023
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 0 | 0 |
| 1978 | 0 | 0 |
| 1979 | 1 | 0 |
| 1980 | 0 | 0 |
| 1981 | 2 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 2 | 0 |
| 1986 | 1 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 1 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 1 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 1 | 0 |
| 1997 | 2 | 0 |
| 1998 | 4 | 0 |
| 1999 | 0 | 0 |
| 2000 | 1 | 0 |
| 2001 | 2 | 0 |
| 2002 | 4 | 1 |
| 2003 | 1 | 1 |
| 2004 | 2 | 1 |
| 2005 | 0 | 1 |
| 2006 | 1 | 1 |
| 2007 | 0 | 4 |
| 2008 | 0 | 0 |
| 2009 | 2 | 0 |
| 2010 | 0 | 1 |
| 2011 | 0 | 1 |
| 2012 | 3 | 1 |
| 2013 | 0 | 2 |
| 2014 | 0 | 0 |
| 2015 | 1 | 2 |
| 2016 | 0 | 0 |
| 2017 | 0 | 1 |
| 2018 | 0 | 1 |
| 2019 | 1 | 1 |
| 2020 | 0 | 0 |
| 2021 | 0 | 0 |
| 2022 | 0 | 0 |
| 2023 | 2 | 2 |
| 2024 | 0 | 2 |
| 2025 | 0 | 0 |
| 2026 | 0 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Cyanine-containing compounds for cancer imaging and treatment29 Aug 2023US 11,738,095 B2Emory University
- NIR to SWIR fluorescent compounds for imaging and detection10 Jan 2023US 11,549,017 B2PerkinElmer Health Sciences, Inc.
- 2-oxo-1,2-dihydrobenzo[cd]indole compound and use thereof22 Jan 2019US 10,183,010 B2Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences
- Substituted dibenzo[FG,OP]tetracenes and formulations or electronic devices containing the same12 May 2015US 9,029,425 B2Merck Patent GmbH
- Compositions useful as inhibitors of voltage-gated sodium channels13 Nov 2012US 8,309,543 B2Vertex Pharmaceuticals Incorporated
- Agonists of small heterodimer partner for cancer therapy3 Sep 2026US 2026/0257992 A1The Board of Trustees of the University of Illinois
- Covalent Inhibitors As Antiviral Agents3 Oct 2024US 2024/0327334 A1Enanta Pharmaceuticals, Inc.
- Tricyclic compounds to degrade neosubstrates for medical therapy18 Jan 2024US 2024/0018118 A1C 4 Therapeutics, Inc.
- Synthesis of Optically Active Indoline Derivatives Via Ruthenium(II)-Catalyzed Enantioselective C-H Functionalization7 Sep 2023US 2023/0278959 A1Mississippi State University
- Nir to swir fluorescent compounds for imaging and detection25 May 2023US 2023/0159762 A1PerkinElmer Health Sciences, Inc.
Most cited
By later US patents
- 1-benzenesulfonyl-1-1,3-dihydroindol-2-one derivatives, their preparation and pharmaceutical compositions in which they are present40US 5,849,780 ASanofi · 1998
- 1-benzenesulfonyl-1,3-dihydro-indol-2-one derivatives, their preparation and pharmaceutical compositions in which they are present39US 5,663,431 ASanofi · 1997
- 1-benzenesulfonyl-1,3-dihydro-indol-2-one derivatives, their preparation and pharmaceutical compositions in which they are present33US 5,686,624 ASanofi · 1997
- 1-benzenesulfonyl-1,3-dihydroindol-2-one derivatives, their preparation and pharmaceutical compositions in which they are present29US 5,726,322 ASanofi · 1998
- 1-benzenesulfonyl-1,3-dihydro-indol-2-one derivatives, their preparation and pharmaceutical compositions in which they are present27US 5,728,723 ASanofi · 1998